Your browser doesn't support javascript.
loading
Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials.
Gasperoni, Lorenzo; Masini, Carla; Toscano, Giada; Cafaro, Alessandro; Zani, Chiara; Andrianò, Cristina; Silimbani, Paolo; Donati, Caterina; Bortolin, Giorgia; Cecco, Sara.
Afiliación
  • Gasperoni L; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Masini C; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Toscano G; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Cafaro A; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Zani C; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Andrianò C; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Silimbani P; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Donati C; Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
  • Bortolin G; Hospital Pharmacy Unit-CRO Aviano, National Cancer Institute IRCCS, Friuli-Venezia Giulia, 33081 Aviano, Italy.
  • Cecco S; Hospital Pharmacy Unit-CRO Aviano, National Cancer Institute IRCCS, Friuli-Venezia Giulia, 33081 Aviano, Italy.
Curr Oncol ; 31(5): 2867-2873, 2024 05 16.
Article en En | MEDLINE | ID: mdl-38785499
ABSTRACT
Investigational drug services need to be organised in a structured approach, especially for sites with a large number of ongoing clinical trials. The aim of this study was to develop a tool to assess the complexity of pharmacy involvement in a sponsored oncology clinical trial. Categorisation into ordinal complexity categories was used to assess the complexity of the clinical trials for consistent pharmacy grant applications. The 15 items of the tool were divided into three sections, and individual item scores were agreed upon among four pharmacists with experience in the conduct of clinical trials at two different centres. A final version of the tool, named Pharm-CAT, was approved. The pharmacists were instructed to use Pharm-CAT to assign a score to each new sponsored trial. To determine the cut-offs for the complexity categories, the scores were sorted in ascending order and the cut-offs corresponding to the first and third tertiles of the score distribution were selected. To verify the reproducibility of the results, Pharm-CAT was applied by two pharmacists independently for each trial. Pharm-CAT proved to be user-friendly. Sixty clinical trials were evaluated and a total of 120 scores were recorded. Low-complexity scores ranged from 0 to 19, medium-complexity scores ranged from 20 to 25, and high-complexity scores were 26 or higher. The average score recorded was 22.88 points. Prospective multicentre validation of Pharm-CAT is needed to confirm its applicability.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto Límite: Humans Idioma: En Revista: Curr Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto Límite: Humans Idioma: En Revista: Curr Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia